Enzymology in Drug Discovery

Enzymes are the macromolecular and micromolecular proteins in the drug design that act as drug targets for the diseases in the process of discovery of drugs as well as its development. There are a number of drug targets which are involved in the designing of the drugs. Drug target is a nucleic acid or a protein whose activity can be modified by a drug itself. The drug can be a chemical compound with a small molecular weight or a biological compound, such as an antibody or a recombinant protein. The drug target should be effective in the disease by relevant in vitro or in vivo models and analysis.

  • Drug designing using enzymes
  • Drug development using enzymes
  • Drug modelling
  • Drug targeting

Related Conference of Enzymology in Drug Discovery

October 30 - 31, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand
November 8-9, 2017

International Summit on Nanotechnology and Medical Robots

New Orleans, Louisiana, USA
November 13-14, 2017

9th International Conference on Bioinformatics

Paris, France
March 12-14, 2018

Glycobiology Biochem Conference 2018

Paris, France
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany

Enzymology in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in